Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17896204 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M...
Conditions: Skin Cancer;   Melanoma;   Metastatic Melanoma
Interventions: Biological: Aldesleukin;   Biological: CD8 enriched Young TIL

Indicates status has not been verified in more than two years